Joanne Wei-un Jang, M.D.,Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Genital Neoplasms, Female | 3 | 2023 | 538 | 0.820 |
Why?
|
Brachytherapy | 3 | 2023 | 1239 | 0.580 |
Why?
|
Carcinoma, Endometrioid | 1 | 2019 | 276 | 0.540 |
Why?
|
Osteoradionecrosis | 1 | 2012 | 51 | 0.420 |
Why?
|
Oropharyngeal Neoplasms | 2 | 2013 | 491 | 0.360 |
Why?
|
Skull Base | 1 | 2012 | 291 | 0.340 |
Why?
|
Endometrial Neoplasms | 1 | 2019 | 1362 | 0.340 |
Why?
|
Skull Base Neoplasms | 1 | 2012 | 269 | 0.330 |
Why?
|
Enteral Nutrition | 1 | 2013 | 782 | 0.280 |
Why?
|
Mammary Neoplasms, Experimental | 2 | 2006 | 500 | 0.270 |
Why?
|
Wnt1 Protein | 1 | 2006 | 120 | 0.270 |
Why?
|
Salvage Therapy | 1 | 2012 | 1265 | 0.250 |
Why?
|
Proto-Oncogene Proteins c-myc | 2 | 2006 | 996 | 0.220 |
Why?
|
Androgen Antagonists | 1 | 2012 | 1443 | 0.210 |
Why?
|
Prostate-Specific Antigen | 1 | 2012 | 2525 | 0.200 |
Why?
|
Prostatic Neoplasms | 2 | 2017 | 11324 | 0.200 |
Why?
|
Isoenzymes | 1 | 2006 | 1690 | 0.190 |
Why?
|
Radiotherapy Dosage | 4 | 2023 | 2895 | 0.180 |
Why?
|
Quality of Life | 2 | 2023 | 13285 | 0.180 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 2 | 2006 | 1708 | 0.170 |
Why?
|
Radiotherapy, Intensity-Modulated | 2 | 2013 | 801 | 0.140 |
Why?
|
Carboplatin | 1 | 2019 | 789 | 0.130 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2013 | 9271 | 0.120 |
Why?
|
Colon, Sigmoid | 1 | 2014 | 123 | 0.110 |
Why?
|
Gastrostomy | 2 | 2013 | 322 | 0.110 |
Why?
|
Hysterectomy | 1 | 2019 | 903 | 0.110 |
Why?
|
Cost of Illness | 1 | 2023 | 1937 | 0.110 |
Why?
|
Disease-Free Survival | 3 | 2013 | 6814 | 0.110 |
Why?
|
Combined Modality Therapy | 2 | 2017 | 8548 | 0.100 |
Why?
|
Organs at Risk | 1 | 2014 | 358 | 0.100 |
Why?
|
Seminal Vesicles | 1 | 2012 | 107 | 0.100 |
Why?
|
Tosyl Compounds | 1 | 2012 | 112 | 0.100 |
Why?
|
Flutamide | 1 | 2012 | 95 | 0.100 |
Why?
|
Paclitaxel | 1 | 2019 | 1716 | 0.100 |
Why?
|
Goserelin | 1 | 2012 | 127 | 0.100 |
Why?
|
Neck Dissection | 1 | 2013 | 200 | 0.100 |
Why?
|
Nutritional Support | 1 | 2013 | 174 | 0.090 |
Why?
|
Uterine Cervical Neoplasms | 1 | 2023 | 2016 | 0.090 |
Why?
|
Narcotics | 1 | 2013 | 336 | 0.090 |
Why?
|
Health Expenditures | 1 | 2023 | 2354 | 0.090 |
Why?
|
Neoplasm Staging | 2 | 2017 | 11125 | 0.090 |
Why?
|
Leuprolide | 1 | 2012 | 320 | 0.090 |
Why?
|
Antineoplastic Agents | 1 | 2012 | 13625 | 0.080 |
Why?
|
Rectum | 1 | 2014 | 896 | 0.080 |
Why?
|
Anilides | 1 | 2012 | 409 | 0.080 |
Why?
|
Urinary Bladder | 1 | 2014 | 1166 | 0.070 |
Why?
|
Nitriles | 1 | 2012 | 954 | 0.070 |
Why?
|
GTP-Binding Proteins | 2 | 2001 | 951 | 0.060 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2013 | 3518 | 0.060 |
Why?
|
Time Factors | 3 | 2017 | 40083 | 0.060 |
Why?
|
Forecasting | 1 | 2013 | 2928 | 0.060 |
Why?
|
Analysis of Variance | 1 | 2012 | 6239 | 0.050 |
Why?
|
Signal Transduction | 1 | 2006 | 23328 | 0.050 |
Why?
|
Pandemics | 1 | 2023 | 8604 | 0.050 |
Why?
|
Prostatectomy | 1 | 2012 | 1943 | 0.050 |
Why?
|
Residence Characteristics | 1 | 2013 | 2035 | 0.050 |
Why?
|
Transgenes | 1 | 2006 | 1006 | 0.050 |
Why?
|
Enzyme Activation | 2 | 2006 | 3604 | 0.050 |
Why?
|
Middle Aged | 5 | 2019 | 219628 | 0.050 |
Why?
|
Carcinoma | 1 | 2013 | 2335 | 0.050 |
Why?
|
Monomeric GTP-Binding Proteins | 2 | 2001 | 200 | 0.050 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2006 | 1248 | 0.050 |
Why?
|
Weight Loss | 1 | 2013 | 2673 | 0.050 |
Why?
|
Humans | 10 | 2023 | 759098 | 0.050 |
Why?
|
Female | 8 | 2023 | 390174 | 0.050 |
Why?
|
Saccharomyces cerevisiae Proteins | 2 | 2001 | 1861 | 0.050 |
Why?
|
Aged, 80 and over | 2 | 2017 | 58864 | 0.040 |
Why?
|
Cyclin B | 1 | 1999 | 104 | 0.040 |
Why?
|
Cell Cycle Proteins | 2 | 2001 | 3449 | 0.040 |
Why?
|
Survival Rate | 1 | 2013 | 12793 | 0.040 |
Why?
|
Fungal Proteins | 2 | 2001 | 911 | 0.040 |
Why?
|
Treatment Outcome | 2 | 2017 | 64867 | 0.040 |
Why?
|
Mitosis | 2 | 2001 | 1195 | 0.040 |
Why?
|
Phosphoprotein Phosphatases | 1 | 1999 | 330 | 0.040 |
Why?
|
Protein Tyrosine Phosphatases | 1 | 1999 | 458 | 0.040 |
Why?
|
Mice, Transgenic | 2 | 2006 | 9501 | 0.030 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2006 | 2824 | 0.030 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2006 | 2925 | 0.030 |
Why?
|
Body Mass Index | 1 | 2013 | 12871 | 0.030 |
Why?
|
Protein Kinases | 1 | 2001 | 1612 | 0.030 |
Why?
|
Saccharomyces cerevisiae | 2 | 2001 | 2704 | 0.030 |
Why?
|
Male | 4 | 2017 | 358602 | 0.030 |
Why?
|
Xerostomia | 1 | 2013 | 94 | 0.030 |
Why?
|
Cell Cycle | 1 | 2001 | 2936 | 0.030 |
Why?
|
Prospective Studies | 1 | 2017 | 54190 | 0.030 |
Why?
|
Aged | 2 | 2017 | 168615 | 0.030 |
Why?
|
Esophageal Stenosis | 1 | 2013 | 194 | 0.020 |
Why?
|
Follow-Up Studies | 1 | 2013 | 39213 | 0.020 |
Why?
|
Developing Countries | 1 | 2023 | 2862 | 0.020 |
Why?
|
Tomography, X-Ray Computed | 1 | 2014 | 20461 | 0.020 |
Why?
|
Cohort Studies | 1 | 2013 | 41266 | 0.020 |
Why?
|
Observer Variation | 1 | 2014 | 2596 | 0.020 |
Why?
|
Deglutition Disorders | 1 | 2013 | 629 | 0.020 |
Why?
|
Adenocarcinoma | 1 | 2004 | 6312 | 0.020 |
Why?
|
Retrospective Studies | 2 | 2014 | 80125 | 0.020 |
Why?
|
Mutation | 2 | 2006 | 29878 | 0.010 |
Why?
|
In Situ Nick-End Labeling | 1 | 2004 | 612 | 0.010 |
Why?
|
Blotting, Northern | 1 | 2004 | 1545 | 0.010 |
Why?
|
Mice | 2 | 2006 | 80993 | 0.010 |
Why?
|
Cyclin-Dependent Kinase Inhibitor Proteins | 1 | 1999 | 52 | 0.010 |
Why?
|
ras Proteins | 1 | 2004 | 1052 | 0.010 |
Why?
|
Remission Induction | 1 | 2004 | 2388 | 0.010 |
Why?
|
Cell Nucleolus | 1 | 1999 | 156 | 0.010 |
Why?
|
Adult | 1 | 2013 | 219353 | 0.010 |
Why?
|
Gene Silencing | 1 | 2004 | 1512 | 0.010 |
Why?
|
DNA, Ribosomal | 1 | 1999 | 286 | 0.010 |
Why?
|
DNA, Fungal | 1 | 1999 | 278 | 0.010 |
Why?
|
Animals | 2 | 2006 | 167531 | 0.010 |
Why?
|
Cyclins | 1 | 1999 | 594 | 0.010 |
Why?
|
Macromolecular Substances | 1 | 1999 | 1432 | 0.010 |
Why?
|
DNA Mutational Analysis | 1 | 2004 | 4111 | 0.010 |
Why?
|
Plasmids | 1 | 2001 | 2277 | 0.010 |
Why?
|
Cloning, Molecular | 1 | 2001 | 4170 | 0.010 |
Why?
|
United States | 1 | 2023 | 72238 | 0.010 |
Why?
|
Kinetics | 1 | 2001 | 6373 | 0.010 |
Why?
|
Recurrence | 1 | 2004 | 8465 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 2001 | 6070 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 2001 | 6538 | 0.010 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2004 | 8489 | 0.000 |
Why?
|
Apoptosis | 1 | 2004 | 9470 | 0.000 |
Why?
|
Models, Biological | 1 | 1999 | 9460 | 0.000 |
Why?
|